Literature DB >> 6327832

Effects of adenosine and 2'-deoxyadenosine on epidermal keratinocyte proliferation: its relation to cyclic AMP formation.

H Iizuka, R Adachi, H Koizumi, T Aoyagi, A Ohkawara, Y Miura.   

Abstract

Although it has been reported that adenosine has an inhibitory effect on keratinocyte proliferation at both G2 and S phases of the cell cycle, its relation to cyclic AMP formation through the adenylate cyclase system has been less well characterized. In order to determine the precise mechanism of the adenosine effect, another physiologic adenine nucleoside, 2'-deoxyadenosine was employed. 2'-Deoxyadenosine was shown to be remarkably different from adenosine in its ability to stimulate the epidermal adenylate cyclase; whereas adenosine markedly increased cyclic AMP levels of pig epidermis, deoxyadenosine had a much weaker effect on the cyclic AMP levels of the skin. Using several parameters of cell proliferation, comparison was made between the effects of these two compounds. Pig keratinocyte explant culture system was employed for the measurement of outgrowth and mitosis. Mitosis was determined after 72-h incubation (to monitor the overall cell proliferation inhibition) and 4-h incubation (to monitor G2 phase inhibition) with the chemicals. Pig skin keratome slice system was employed for [3H]thymidine uptake measurement. Both adenosine and deoxyadenosine were shown to have marked inhibitory effects on keratinocyte out-growth, [3H]thymidine uptake, and keratinocyte mitosis. The effects of deoxyadenosine on outgrowth and [3H]thymidine uptake were greater than that of adenosine. The inhibitory effect of adenosine and deoxyadenosine on mitosis were about the same in both 4-h and 72-h incubation systems. Thus deoxyadenosine, which is a much weaker stimulator of epidermal adenylate cyclase, was also shown to be as potent an inhibitor of keratinocyte proliferation as adenosine. These results further substantiate the view that cyclic AMP elevating agents (such as adenosine and deoxyadenosine) might not necessarily reveal their inhibitory effects on keratinocyte proliferation through their effects of cyclic AMP formation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327832     DOI: 10.1111/1523-1747.ep12261448

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Reduced superoxide dismutase activity in UVB-induced hyperproliferative pig epidermis.

Authors:  Y Hashimoto; N Ohkuma; H Iizuka
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Receptor-linked adenylate cyclase in the membranes of cultured human epidermal keratinocytes.

Authors:  M T Cavey; D Cavey; B Shroot; U Reichert; J Gazith
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes.

Authors:  A Haegerstrand; B Jonzon; C J Dalsgaard; J Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  UVB-induced calmodulin increase in pig epidermis: analysis of the effect of the calmodulin antagonist, W-13.

Authors:  A Takagi; H Iizuka
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Pig-skin epidermal calmodulin: effects of antagonists of calmodulin on DNA synthesis of pig-skin epidermis.

Authors:  H Iizuka; Y Hashimoto; M Hirokawa; S Matsuo; T Mizumoto; A Ohkawara
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  Dimethyl sulfoxide-induced augmentation of adenosine-adenylate cyclase response of pig skin epidermis.

Authors:  M Watanabe; H Iizuka
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 7.  Metabolities from Marine Sponges of the Genus Callyspongia: Occurrence, Biological Activity, and NMR Data.

Authors:  Lucas Hilário Nogueira de Sousa; Rusceli Diego de Araújo; Déborah Sousa-Fontoura; Fabrício Gava Menezes; Renata Mendonça Araújo
Journal:  Mar Drugs       Date:  2021-11-26       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.